Donna DeAltier Pickard a.k.a. “Donna P” or Shakima transitioned into eternal life on July 24, 2026. She was 63 years old.
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the ...
- Obexelimab BLA submission for the treatment of IgG4-RD accepted by FDA; PDUFA target action date of May 27,2027 - WALTHAM, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE)-- Zenas BioPharma, Inc. ("Zenas” or ...
- Obexelimab BLA submission for the treatment of IgG4-RD accepted by FDA; PDUFA target action date of May 27,2027 - -New study data confirm bioequivalence of obexelimab single-dose prefilled ...
Zenas BioPharma is positioned as more than a rare-disease play, leveraging obexelimab’s B-cell inhibition platform for multiple autoimmune indications. ZBIO’s Phase 3 INDIGO trial validates obexelimab ...
Law360 (June 30, 2026, 8:00 PM EDT) -- A Massachusetts federal judge has permanently dismissed an investor suit alleging Zenas BioPharma hid how quickly it was spending money before its 2024 initial ...
Zenas BioPharma (ZBIO) added ~8% in the premarket on Thursday after the chief executive of the clinical-stage biotech continued a recent trend of buying shares of the company, adding more than $1M ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Rising footwear designer Chiso Osuji wears many hats, between working a corporate consulting job and running her up-and-coming luxury brand Zena Ziora as a one-woman team. Inspired by her matrilineal ...
He threw more innings in a season than any player since 1917. A three-time All-Star, he also had four 20-win seasons. By Victor Mather Wilbur Wood, the Chicago White Sox knuckleballer who started more ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zenas BioPharma (NASDAQ: ZBIO) shares fell more than 50% in the last trading session following the release of Phase 3 results for obexelimab in patients with immunoglobulin G4-related disease (IgG4-RD ...